Treatment (T) of T2 N0-1 larynx cancer (LC) with hyperfractionated radiotherapy (HRT) and cetuximab (C): Final report

Giglio, R. E. ; Navigante, A. ; Pereira, M. D. ; Califano, L. ; Roth, B. M. C. ; Saco, P. ; Castro, M. A. ; Menendez, P. ; Aguerre, P. ; Adan, R. ; Brosio, C. ; Pogany, C.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5570-5570 [Periódico revisado por pares]

Texto completo disponível